1. Which therapy was tested in the REDUCE-IT trial?

2. Which of the following statements is true about the STRENGTH and REDUCE-IT clinical trials?

3. Which of the following statements is true about the achieved level of serum or plasma EPA in the JELIS, STRENGTH, and REDUCE-IT clinical trials?

4. The starting dose of icosapent ethyl is:

« Return to Activity